e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Microbiological advances in the diagnosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Resazurin microtitre assay (REMA) plate – A simple, rapid and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis
S. Kunte, A. Karmarkar, S. Dharmashale, S. Hatolkar (Pune, India)
Source:
Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Session:
Microbiological advances in the diagnosis of tuberculosis
Session type:
Poster Discussion
Number:
1412
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Kunte, A. Karmarkar, S. Dharmashale, S. Hatolkar (Pune, India). Resazurin microtitre assay (REMA) plate – A simple, rapid and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Eur Respir J 2012; 40: Suppl. 56, 1412
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Line probe assay (LiPA) based rapid detection of multiple drug resistent (MDR) mycobacterium tuberculosis (MTB)
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Rapid resistance detection of
Mycobacterium tuberculosis
to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system.
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Evaluation of a line probe assay kit for direct and simultaneous detection of mycobacterium tuberculosis complex and its resistance to rifampin
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Evaluation of a rapid bactriophage assay for the detection of
mycobacterium tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Colorimetric assays for rapid drug susceptibility testing of
Mycobacterium tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 167s
Year: 2003
Xpert MTB/RIF assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Validation of the MGIT 960 technique for 2
nd
line drug susceptibility testing (DST) of
Mycobacterium tuberculosis
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
The results of drug susceptibility testing of mycobacterium tuberculosis to rifampicin by Xpert® MTB / Rif, BACTEC MGIT 960 as compared with the method of seeding on solid nutrient media
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Source: Eur Respir J 2008; 32: 1165-1174
Year: 2008
The Abbott LCx-MTB assay is more sensitive than culture on Loewenstein Jensen medium for detection of mycobacterium tuberculosis in respiratory specimens and time of sputum conversion in response to antituberculous treatment strongly correlates between
Source: Eur Respir J 2002; 20: Suppl. 38, 580s
Year: 2002
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Compatibility of a novel filter paper-based bio-safe sputum transport kit with line probe assay for diagnosing drug-resistant tuberculosis: a single-site evaluation study
Source: ERJ Open Res, 7 (3) 00137-2021; 10.1183/23120541.00137-2021
Year: 2021
Evaluation of mycobacteria growth in the presence of combinations of antituberculous drugs using colorimetric method
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary
Mycobacterium avium-intracellulare
complex (MAC) disease
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay
Source: Eur Respir J 2007; 29: 605-607
Year: 2007
Comparison of rapid in-house methods for drug susceptibility testing of
mycobacterium tuberculosis
with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Efficacy of treatment of MDR/XDR TB patients based on rapid diagnostics of
M. tuberculosis
drug resistance by
GenoType MTBDRplus and GenoType MTBDRsl (Hain Lifescience GmbH, Germany)
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
GenoType MTBDRsl performance on clinical samples with diverse genetic background},
Source: Eur Respir J 2012; 40: 690-698
Year: 2012
Comparison between the diagnostic yield of tissue Xpert MTB/Rif assay and culture in pleural tuberculosis patients.
Source: International Congress 2019 – Interventional pulmonology: a mixture of spices
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept